The homoarginine is proposed as a prognostic metabolic criterion of danger of stroke and myocardium infarction and evaluated in this capacity in a number of population studies. The actual study analyzed content of this cardio-metabolic marker and main amino acids in blood plasma of 59 patients (46 males and 13 females, aged 61,4 ± 6,2 years) wit6h ischemic heart disease send to planned operation of aortocoronary bypass surgery and also 30 healthy individuals aged 50,4 ± 9,2 years. The concentration of homoarginine and amino acids was detected using high-performance liquid chromatography with identification of ortho-phthalic derivative with fluorometric detecting using genuine developed technique. The examined patients had a significant decreasing of level of homoarginine in venous blood plasma. In contrast to healthy individuals, the patients were detected a positive dependence of level of homoarginine from content of level of lysine and arginine in blood plasma. These amino acids are substrates of reaction generating homoarginine catalyzed by argin ineglycineamidinotransferase. Thus, in patients' level of homoarginine in blood plasma depends both on activity of argininegly cineamidinotransferase in tissues and on content of lysine and arginine. The content of these amino acids in blood can abruptly increase at activation of coagulation and fibrinolysis. Consequently, it appears that increasing of bio-synthesis of homoarginine occurs in certain patients leveling its decreased level. In patients with cardio-vascular diseases at detection of homoarginine a level of arginine and lysine in blood is to be considered.